Loading clinical trials...
Loading clinical trials...
A Prospective Randomized-controlled Study on Effectiveness of Extended-release Liposomal Bupivacaine in Postoperative Pain Control
Conditions
Interventions
Exparel
Bupivacaine hydrochloride
+1 more
Locations
1
United States
Department of Cardiothoracic and Vascular Surgery and Memorial Hermann Heart and Vascular Institute - Texas Medical Center
Houston, Texas, United States
Start Date
November 20, 2013
Primary Completion Date
May 3, 2017
Completion Date
June 30, 2017
Last Updated
October 16, 2018
NCT06862609
NCT07327463
NCT07436806
NCT07442721
NCT07440940
NCT07413055
Lead Sponsor
The University of Texas Health Science Center, Houston
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions